Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Data Dashboard topic
No spam. Unsubscribe anytime.
HSS presents Q3 Express Dashboard showing steady utilization and a small uptick in cost per employee
Summary
Marina Coleridge presented the Q3 Express Dashboard showing generally steady trends in medical and prescription spend, a cost‑per‑employee figure of about $12,982 per year (up ~1.7%), and declining chronic condition prevalence in several categories; the board asked for clarifications on calculation methods and totals.
Marina Coleridge, enterprise systems and analytics manager, presented the HSS Q3 Express Dashboard covering non‑Medicare and Medicare populations. The dashboard compiled utilization metrics, high‑cost claimant profiles, preventive screening measures and chronic condition prevalence trends. Coleridge reported that medical and Rx spending trends were broadly consistent with recent quarters, with a slight uptick compared to the lowest point earlier in the year.
Key figures: Coleridge said the cost per employee per year in 2017 tracked at roughly $12,982 (about a 1.7% increase year over year). She noted high‑cost claimants continue to drive a disproportionate share of costs (approximately 1.9% of members were responsible for about 40% of allowed dollars). Preventive screening rates and chronic condition prevalence were included as working metrics; Coleridge cautioned that some preventative screening numbers are not yet calculated to HEDIS rules and that a HEDIS‑compliant rules engine would require additional resources.
Board members asked for methodological clarity on several items where the 'total' column was higher than component plan averages; Coleridge and AON clarified that totals may include non‑plan populations (COBRA, cross‑plan membership) and can double‑count members who switched plans over the reporting window. She committed to provide follow‑up analyses to reconcile anomalies and to consider adding a HEDIS‑compliant screening measure in future dashboards.
Coleridge and staff also noted planned updates: refining benchmarks, addressing risk‑score spikes observed in recent months and delivering clearer explanatory footnotes so board members can interpret plan comparisons and totals consistently.
